The U.S. FDA has granted 510(k) clearance to Sonic Incytes’ Velacur ONE, an AI-guided point-of-care ultrasound elastography device designed to support the diagnosis and management of chronic liver diseases including MASH and MASLD.
If you ask most people to define healthcare, they’ll likely describe what happens after someone becomes sick and begins receiving care. But could healthcare begin before illness ever showed up?
RadNet has confirmed the acquisition of See-Mode Technologies PTE LTD, a global innovator in artificial intelligence (AI) for ultrasound imaging. The move marks a significant expansion of RadNet's capabilities in AI-powered diagnostic imaging.
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.